Nevro (NVRO) announced the publication of new data in Medical Devices: Evidence and Research, which demonstrate the superiority of the Nevro1 SI Joint Fusion System, a posterior integrated transfixation cage system offering enhanced stability, minimized bone removal and increased fusion potential compared to a posterolateral cylindrical threaded single-implant system. Nevro1’s performance also showed that it is equivalent in osteopenic bone when compared to a lateral triangular rod system in healthy bone. Results concluded: Nevro1 and the lateral triangular rods produced equivalent motion reduction in all motion planes. Posterolateral cylindrical threaded implant produced less motion reduction than Nevro1 and lateral implants in flexion-extension. Using Nevro1 for the treatment of SI joint-related pain allows for the most surface area for fusion, which provides a significantly better opportunity for robust SI joint arthrodesis.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio